Specific Language Important in Heart Failure Communication

This article originally appeared here.
Share this content:
Specific Language Important in Heart Failure Communication
Specific Language Important in Heart Failure Communication

MONDAY, May 16, 2016 (HealthDay News) -- Specific language is important for patient experience and shared decision-making in heart failure, according to research published in the June 1 issue of The American Journal of Cardiology.

Anne M. Kelemen, from the MedStar Washington Hospital Center in Washington, D.C., and colleagues discuss the importance of communication between clinicians and patients with heart failure.

The researchers note that, based on studies from patients with heart failure, when engaging in complex communication, specific language is important in patient experience and in shared decision-making with providers. Although clinical reports have outlined useful frameworks for communication, they have not yet discussed specific language for furthering holistic care, especially in the emotionally charged and complex areas of advancing disease and transitions to end-of-life care. Specific language can be useful for communicating information to patients, including phrases such as: "the [specific therapy] is no longer working," instead of "you are failing the therapy;" "the therapy will not help you achieve your goal/s" instead of "you are not a candidate for the therapy;" and "focusing care on managing pain and symptoms of disease progression" rather than "keeping the patient comfortable."

"Specific phrasing may significantly impact patient experiences and outcomes," the authors write. "Communication that focuses on the disease itself and the therapy or intervention in question may help remove the patient from potential negative emotions, thus facilitating more objective shared decision-making with the clinician."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »